Short-term treatment with metformin suppresses toll like receptors (TLRs) activity in isoproterenol-induced myocardial infarction in rat: Are AMPK and TLRs connected?

International Immunopharmacology

Volumn 14, Issue 4, 2012, Pages 785-791

  Soraya, Hamid ^a   Farajnia, Safar ^b   Khani, Sajjad ^c   Rameshrad, Maryam ^a   Khorrami, Arash ^a   Banani, Armita ^a   Maleki Dizaji, Nasrin ^a   Garjani, Alireza ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

AMP activated protein kinase; Metformin; MyD88; Myocardial infarction; Toll like receptors

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INTERLEUKIN 6; ISOPRENALINE; METFORMIN; MYELOID DIFFERENTIATION FACTOR 88; MYELOPEROXIDASE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; HEART INFARCTION; IMMUNOREGULATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; RAT; SHORT COURSE THERAPY; TISSUE LEVEL; UPREGULATION;

ADRENERGIC BETA-AGONISTS; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; GENE EXPRESSION REGULATION; HYPOGLYCEMIC AGENTS; INTERLEUKIN-6; ISOPROTERENOL; MALE; METFORMIN; MYOCARDIAL INFARCTION; PHOSPHORYLATION; RANDOM ALLOCATION; RATS; RATS, WISTAR; TOLL-LIKE RECEPTORS;

EID: 84868709462     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2012.10.014     Document Type: Article

References (38)

1. F. Abbasi, J.W. Chu, T. McLaughlin, C. Lamendola, E.T. Leary, and G.M. Reaven Effect of metformin treatment on multiple cardiovascular disease risk factors in patients with type 2 diabetes mellitus Metabolism 53 2004 159 164
2. UK Prospective Diabetes Study (UKPDS) Group Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) Lancet 352 1998 854 865
3. M. Yin, I.C. van der Horst, J.P. van Melle, C. Qian, W.H. Van Gilst, and H.H. Silljé Metformin improves cardiac function in a nondiabetic rat model of post-MI heart failure Am J Physiol Heart Circ Physiol 301 2011 H459 H468
4. X.F. Wang, J.Y. Zhang, L. Li, X.Y. Zhao, H.L. Tao, and L. Zhang Metformin improves cardiac function in rats via activation of AMP-activated protein kinase Clin Exp Pharmacol Physiol 38 2 2011 94 101
5. R.J. Legtenberg, R.J. Houston, B. Oeseburg, and P. Smits Metformin improves cardiac functional recovery after ischemia in rats Horm Metab Res 34 2002 182 185
6. S. Verma, and J.H. McNeill Metformin improves cardiac function in isolated streptozotocin-diabetic rat hearts Am J Physiol 266 1994 H714 H719
7. M.R. Owen, E. Doran, and A.P. Halestrap Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain Biochem J 348 2000 607 614
8. L.H. Opie, P.J. Commerford, B.J. Gersh, and M.A. Pfeffer Controversies in ventricular remodeling Lancet 367 2006 356 367
9. S. Frantz, G. Ertl, and J. Bauersachs Toll-like receptor signaling in the ischemic heart Front Biosci 13 2008 5772 5779
10. D.L. Mann The emerging role of innate immunity in the heart and vascular system: for whom the cell tolls Circ Res 108 2011 1133 1145
11. J.E. Jordan, Z.Q. Zhao, and J. Vinten-Johansen The role of neutrophils in myocardial ischemia-reperfusion injury Cardiovasc Res 43 1999 860 878
12. L. Timmers, G. Pasterkamp, V.C. de Hoog, F. Arslan, Y. Appelman, and D.P. de Kleijn The innate immune response in reperfused myocardium Cardiovasc Res 94 2012 276 283
13. F. Arslan, D.P. de Kleijn, and G. Pasterkamp Innate immune signaling in cardiac ischemia Nat Rev Cardiol 8 2011 292 300
14. S. Frantz, G. Ertl, and J. Bauersachs Mechanisms of disease: toll-like receptors in cardiovascular disease Nat Clin Pract Cardiovasc Med 4 2007 444 454
15. J.I. Oyama, C. Blais, X. Liu, M. Pu, L. Kobzik, and R.A. Kelly Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice Circulation 109 2004 784 789
16. F. Arslan, M.B. Smeets, L.A. O'Neill, B. Keogh, P. McGuirk, and L. Timmers Myocardial ischemia/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibody Circulation 121 2010 80 90
17. Y. Feng, H. Zhao, X. Xu, E.S. Buys, M.J. Raher, and J.C. Bopassa Innate immune adaptor MyD88 mediates neutrophil recruitment and myocardial injury after ischemia-reperfusion in mice Am J Physiol Heart Circ Physiol 295 2008 H1311 H1318
18. H. Yuan, L. Li, W. Zheng, J. Wan, P. Ge, and H. Li Antidiabetic drug metformin alleviates endotoxin-induced fulminant liver injury in mice Int Immunopharmacol 12 2012 682 688
19. S. Giri, N. Nath, B. Smith, B. Viollet, A.K. Singh, and I. Singh 5-Aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside inhibits proinflammatory response in glial cells: a possible role of AMP-activated protein kinase J Neurosci 24 2004 479 487
20. I.J. Benjamin, J.E. Jalil, L.B. Tan, K. Cho, K.T. Weber, and W.A. Clark Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis Circ Res 65 1989 657 670
21. M.A. Omar, S. Verma, and A.S. Clanachan Adenosine-mediated inhibition of 5′-AMP-activated protein kinase and p38 mitogen-activated protein kinase during reperfusion enhances recovery of left ventricular mechanical function J Mol Cell Cardiol 52 2012 1308 1318
22. G. Kewalramani, D. An, M.S. Kim, S. Ghosh, D. Qi, and A. Abrahani AMPK control of myocardial fatty acid metabolism fluctuates with the intensity of insulin-deficient diabetes J Mol Cell Cardiol 42 2007 333 342
23. M.W. Pfaffle A new mathematical model for relative quantification in real time RT-PCR Nucleic Acids Res 29 9 2001 e45
24. K.M. Mullane, R. Kraemer, and B. Smith Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium J Pharmacol Methods 14 1985 157 167
25. Soraya H, Khorrami A, Garjani AF, Maleki-Dizaji N, Garjani A. Acute treatment with metformin improves cardiac function following isoproterenol induced myocardial infarction in rats. Pharmacol Rep 2012; 6(64).
26. J.A. Johnson, S.H. Simpson, E.L. Toth, and S.R. Majumdar Reduced cardiovascular morbidity and mortality associated with metformin use in subjects with Type 2 diabetes Diabet Med 22 2005 497 502
27. S. Gundewar, J.W. Calvert, S. Jha, I. Toedt-Pingel, S.Y. Ji, and D. Nunez Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure Circ Res 104 2009 403 411
28. M. Paiva, N.P. Riksen, S.M. Davidson, D.J. Hausenloy, P. Monteiro, and L. Gonçalves Metformin prevents myocardial reperfusion injury by activating the adenosine receptor J Cardiovasc Pharmacol 53 2009 373 378
29. S. El Messaoudi, G.A. Rongen, R.A. de Boer, and N.P. Riksen The cardioprotective effects of metformin Curr Opin Lipidol 22 2011 445 453
30. D.G. Hardie, S.A. Hawley, and J.W. Scott AMP-activated protein kinase - development of the energy sensor concept J Physiol 574 2006 7 15
31. R.R. Russell III, J. Li, D.L. Coven, M. Pypaert, C. Zechner, and M. Palmeri AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury J Clin Invest 114 2004 495 503
32. R. Saeedi, H.L. Parsons, R.B. Wambolt, K. Paulson, V. Sharma, and J.R. Dyck Metabolic actions of metformin in the heart can occur by AMPK-independent mechanisms Am J Physiol Heart Circ Physiol 294 2008 H2497 H2506
33. H.N. Cha, J.H. Choi, Y.W. Kim, J.Y. Kim, M.W. Ahn, and S.Y. Park Metformin inhibits isoproterenol-induced cardiac hypertrophy in mice Korean J Physiol Pharmacol 14 2010 377 384
34. T. Shishido, N. Nozaki, S. Yamaguchi, Y. Shibata, J. Nitobe, and T. Miyamoto Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction Circulation 108 2003 2905 2910
35. L. Timmers, J.P. Sluijter, J.K. van Keulen, I.E. Hoefer, M.G. Nederhoff, and M.J. Goumans Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction Circ Res 102 2008 257 264
36. M. Satoh, Y. Shimoda, C. Maesawa, T. Akatsu, Y. Ishikawa, and Y. Minami Activated toll-like receptor 4 in monocytes is associated with heart failure after acute myocardial infarction Int J Cardiol 109 2006 226 234
37. G. Vilahur, O. Juan-Babot, E. Peña, B. Oñate, L. Casaní, and L. Badimon Molecular and cellular mechanisms involved in cardiac remodeling after acute myocardial infarction J Mol Cell Cardiol 50 2011 522 533
38. D.G. Hardie AMP-activated protein kinase - an energy sensor that regulates all aspects of cell function Genes Dev 25 2011 1895 1908